← Leaderboards
Thewarach Laha
George Washington University
$975,164
Attributed
$2,925,491
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $673.7K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,925,491 · 1
By mechanism
R01$2,925,491 · 1
Top collaborators
- Paul J Brindley9 shared
- Alexander Constantine Loukas9 shared
Most similar at George Washington University
Same institution · by research overlap
- Jason P Mulvenna$559,615
- Jeffrey S Akman$15,000,000
Others in their field
Other Emerging Leaders on “Crispr/Cas Technology”
- William H. Peranteau · Children'S Hosp Of Philadelphia$16,284,236
- Crystal Mackall · Children'S Hosp Of Philadelphia$13,090,386
- Jacqueline K White · Jackson Laboratory$11,881,166
- Jesse M Engreitz · Stanford University$8,776,071
- Peng Jiang · Rutgers, The State Univ Of N.J.$6,578,144
- Yin Shen · University Of California, San Francisco$6,515,212
Research focus
Crispr/Cas TechnologyFasciola HepaticaCessation Of LifeCountryFar EastExtracellular VesiclesCarcinogenesisCell ProliferationCombatComplementAnti-CancerBile DuctBile Duct CarcinomaAntigensBiliaryBiliary TractCarcinogenicityCarcinogensCholangiocarcinomaCholangiocyteCommunicationCancer TherapyCancer VaccinesFoodborne
Grant awards (9)
Anti-cancer vaccine targeting the host-parasite interface during fluke infection$151,875
R01 · FY2025 · CA
Anti-cancer vaccine targeting the host-parasite interface during fluke infection$139,050
R01 · FY2025 · CA
Anti-cancer vaccine targeting the host-parasite interface during fluke infection$56,808
R01 · FY2025 · CA
Anti-cancer vaccine targeting the host-parasite interface during fluke infection$382,600
R01 · FY2024 · CA
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer$326,864
R01 · FY2022 · CA
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer$334,003
R01 · FY2021 · CA
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer$334,942
R01 · FY2020 · CA
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer$525,697
R01 · FY2019 · CA
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer$673,652
R01 · FY2018 · CA